Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lonnie Loutzenhiser

Orthopaedic Surgery of the Spine Golden, CO Medical Doctor

NPI 1063543007 CMS profile 139300

660 Golden Ridge Rd, Suite 250, Golden, CO 80401

Open in the dashboard

General payments

$201,477

171 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lonnie Loutzenhiser of Golden, CO is reported in the CMS Open Payments database as having received $201,477 across 171 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $67,939 20
2024 General $51,724 28
2023 General $23,900 31
2022 General $3,748 11
2021 General $12,270 20
2020 General $25,367 22
2019 General $16,529 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lonnie Loutzenhiser
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Lonnie Loutzenhiser were reported at $67,939. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Lonnie Loutzenhiser Orthopaedic Surgery of the Spine median Middle half National median
2019 $16,529 $2,106 $337–$18,608 $163
2020 $25,367 $1,213 $156–$15,082 $114
2021 $12,270 $1,834 $271–$15,617 $132
2022 $3,748 $2,015 $320–$17,036 $149
2023 $23,900 $1,925 $336–$14,599 $160
2024 $51,724 $2,110 $341–$12,483 $164
2025 $67,939 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Orthofix Medical, Inc. $136,420 55 payments
  2. Stryker Corporation $24,565 39 payments
  3. Seaspine Orthopedics Corporation $20,018 35 payments
  4. Globus Medical, Inc. $16,535 20 payments
  5. Zimmer Biomet Holdings, Inc. $2,916 11 payments
  6. Alphatec Spine, Inc $484 5 payments
  7. VB Spine LLC $220 1 payment
  8. Highridge Medical LLC $136 2 payments
  9. Integrity Implants Inc $124 1 payment
  10. DePuy Synthes Sales Inc. $35 1 payment
  11. Other $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $145,428 64 payments
  2. Consulting Fee $45,925 23 payments
  3. Travel and Lodging $5,703 25 payments
  4. Food and Beverage $4,421 59 payments
Products named General payments · program years 2019–2025
  1. Physio-Stim $67,322 16 payments
  2. WAVEFORM C $46,388 7 payments
  3. LATERAL ACCESS SPINAL SYSTEM $16,197 8 payments
  4. EVEREST XT $16,197 8 payments
  5. ALEUTIAN TLIF MI $15,197 7 payments
  6. WaveForm TO $9,138 9 payments
  7. EVEREST MI $8,598 5 payments
  8. CAPITOL $8,367 9 payments
  9. WaveForm TA $8,274 4 payments
  10. SAHARA $7,599 3 payments
  11. Other $41,513 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

48

Median for Orthopedic Surgery: 203

Drug cost

$575

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 29 $370
Gabapentin Generic 19 $205

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$157,727

Medicare's payments for the services billed

Medicare patients

311

Average age 74

Services billed

832

170 women, 141 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Ischemic heart disease 29%
Depression 26%
Chronic kidney disease 24%
Diabetes 22%
Osteoporosis 22%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record